Infinity Pharma (INFI) Tops Q1 EPS by 6c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. AVGO
3. CDNS
4. SPY
5. META
6. INTC
7. JBLU
8. ANT
9. NVDA
10. AAPL

Go back to Infinity Pharma (INFI) Tops Q1 EPS by 6c

Infinity Provides Company Update and Reports First Quarter 2017 Financial Results

May 9, 2017 4:02 PM EDT

CAMBRIDGE, Mass., May 9, 2017 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced its first quarter 2017 financial results and provided an update on the company, including its progress with IPI-549, a potentially first-in-class immuno-oncology product candidate that selectively inhibits phosphoinositide-3-kinase gamma (PI3K-gamma). Infinity is evaluating IPI-549 as a monotherapy and in combination with Opdivo® (nivolumab), a PD-1 immune checkpoint inhibitor, in a Phase 1 study in patients with advanced solid tumors. Dose-escalation data from the ongoing study were... More